Form 4: Vaxcyte CEO Sells Shares
Insider Transaction (Form 4)
Grant Pickering, CHIEF EXECUTIVE OFFICER and a Director of Vaxcyte, Inc., sold 18,198 shares of common stock on July 27, 2026.
Summary
- Option exercise/conversion: acquired 16,198 Common Stock at $2.03 ($32,882) on July 27, 2026; holds 469,445 after (Direct).
- Open-market sale: disposed of 11,783 Common Stock at $55.52 ($654,133) on July 27, 2026; holds 457,662 after (Direct).
- Open-market sale: disposed of 4,415 Common Stock at $55.93 ($246,935) on July 27, 2026; holds 453,247 after (Direct).
- Open-market sale: disposed of 756 Common Stock at $55.52 ($41,970) on July 27, 2026; holds 133,459 after (Indirect).
- Open-market sale: disposed of 244 Common Stock at $55.96 ($13,655) on July 27, 2026; holds 133,215 after (Indirect).
- Open-market sale: disposed of 622 Common Stock at $55.54 ($34,546) on July 27, 2026; holds 133,593 after (Indirect).
- Open-market sale: disposed of 378 Common Stock at $55.91 ($21,135) on July 27, 2026; holds 133,215 after (Indirect).
- Option exercise/conversion: disposed of 16,198 Stock Option (right to buy) on July 27, 2026; holds 137,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,012,375 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Grant Pickering — Director, Officer (CHIEF EXECUTIVE OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Option exercise/conversion | Common Stock | 16,198 | $2 | $32.9K | 469,445 |
| 2026-07-27 | Open-market sale | Common Stock | 11,783 | $56 | $654.1K | 457,662 |
| 2026-07-27 | Open-market sale | Common Stock | 4,415 | $56 | $246.9K | 453,247 |
| 2026-07-27 | Open-market sale | Common Stock | 756 | $56 | $42.0K | 133,459 |
| 2026-07-27 | Open-market sale | Common Stock | 244 | $56 | $13.7K | 133,215 |
| 2026-07-27 | Open-market sale | Common Stock | 622 | $56 | $34.5K | 133,593 |
| 2026-07-27 | Open-market sale | Common Stock | 378 | $56 | $21.1K | 133,215 |
| 2026-07-27 | Option exercise/conversion | Stock Option (right to buy) | 16,198 | — | — | 137,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Option exercise/conversion (16,198 shares) |
| 2026-07-27 | Open-market sale (11,783 shares) |
| 2026-07-27 | Open-market sale (4,415 shares) |
| 2026-07-27 | Open-market sale (756 shares) |
| 2026-07-27 | Open-market sale (244 shares) |
| 2026-07-27 | Open-market sale (622 shares) |
| 2026-07-27 | Open-market sale (378 shares) |
| 2026-07-27 | Option exercise/conversion (16,198 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., bearish, Grant Pickering
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.